NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ynno Med

Ynno Med

Private
Hong KongHealthcare & Life Scienceshttps://www.ynnomed.com/

Last Round

Grant

Apr 1, 2025

Total Funding Raised

$1.13M

Company Overview

Ynno Med is a biotech company that has developed a drug R&D platform dedicated to addressing antimicrobial resistance by discovering and developing new antimicrobial agents.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryantimicrobial resistanceAMRnew antibioticsfirst-in-class drugsAI biotechdrug discoverypreclinical drug developmentin silico drug discoverycomputational drug discoverydrug R&D platformbacterial transcription inhibitorsdrug design servicesMRSAdrug candidate licensinggenerative chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ynno Med Comparables

Compare Ynno Med with similar companies based on industry and business-model similarity.

Ynno Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ynno Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2025
Corporate FundingOct 1, 2024
GrantApr 1, 2024
GrantApr 1, 2023
GrantApr 1, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    $115K grant from Innovation and Technology Commission.

  • Oct 1, 2024

    Raised $192K in corporate funding.

Ynno Med Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ynno Med Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ynno Med's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range1
Year Founded2021
Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.